These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28558958)

  • 1. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.
    Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F
    EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer.
    Li C; He X; Zhang L; Li L; Zhao W
    BMC Cancer; 2019 Oct; 19(1):957. PubMed ID: 31615475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
    Han S; Huang T; Li W; Liu S; Yang W; Shi Q; Li H; Ren J; Hou F
    Cell Physiol Biochem; 2018; 48(2):516-527. PubMed ID: 30021192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
    J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer.
    Schmidt M; Petry IB; Böhm D; Lebrecht A; von Törne C; Gebhard S; Gerhold-Ay A; Cotarelo C; Battista M; Schormann W; Freis E; Selinski S; Ickstadt K; Rahnenführer J; Sebastian M; Schuler M; Koelbl H; Gehrmann M; Hengstler JG
    Breast Cancer Res Treat; 2011 Feb; 125(3):637-46. PubMed ID: 20352488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D; Li K; Zhu K; Yan R; Dang C
    Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of neurone glial-related cell adhesion molecule is an independent predictor of poor prognosis in advanced colorectal cancer.
    Chan JY; Ong CW; Salto-Tellez M
    Cancer Sci; 2011 Oct; 102(10):1855-61. PubMed ID: 21718388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression profile and clinicopathological significance of Notch1 in patients with colorectal cancer: a meta-analysis.
    Li G; Zhou Z; Zhou H; Zhao L; Chen D; Chen H; Zou H; Qi Y; Jia W; Pang L
    Future Oncol; 2017 Oct; 13(23):2103-2118. PubMed ID: 28984154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
    Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
    World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.
    Akita H; Nagano H; Takeda Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Takahashi H; Ohigashi H; Tomita Y; Ishikawa O; Mori M; Doki Y
    Oncogene; 2011 Aug; 30(31):3468-76. PubMed ID: 21399662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer.
    Hu L; Chen HY; Cai J; Zhang Y; Qi CY; Gong H; Zhai YX; Fu H; Yang GZ; Gao CF
    BMC Cancer; 2015 Apr; 15():246. PubMed ID: 25884558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of miR-106a in colorectal cancer.
    Hao H; Liu L; Zhang D; Wang C; Xia G; Zhong F; Hu X
    Oncotarget; 2017 Jan; 8(3):5038-5047. PubMed ID: 27926519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma.
    Gong W; Tian M; Qiu H; Yang Z
    Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of membranous Ep-CAM in budding colorectal carcinoma cells.
    Gosens MJ; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
    Mod Pathol; 2007 Feb; 20(2):221-32. PubMed ID: 17361206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma.
    Sun L; Guo C; Burnett J; Yang Z; Ran Y; Sun D
    Oncotarget; 2016 Nov; 7(48):78688-78697. PubMed ID: 27780921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.
    Spizzo G; Went P; Dirnhofer S; Obrist P; Moch H; Baeuerle PA; Mueller-Holzner E; Marth C; Gastl G; Zeimet AG
    Gynecol Oncol; 2006 Nov; 103(2):483-8. PubMed ID: 16678891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.
    Peng Q; Zhang X; Min M; Zou L; Shen P; Zhu Y
    Oncotarget; 2017 Jul; 8(27):44893-44909. PubMed ID: 28415652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.